Aironyl + Apidone

Aironyl + Apidone is a combination therapy consisting of two separate medications commonly used in the management of respiratory and allergic conditions, particularly in pediatric populations. - **Aironyl** contains terbutaline sulfate, a selective beta-2 adrenergic receptor agonist that acts as a bronchodilator by relaxing bronchial smooth muscle, thereby relieving bronchospasm associated with asthma and other obstructive airway diseases[6]. - **Apidone** is a fixed-dose combination of dexamethasone (a potent synthetic glucocorticoid corticosteroid) and chlorpheniramine maleate (a first-generation antihistamine). Dexamethasone provides anti-inflammatory and immunosuppressive effects, while chlorpheniramine blocks H1 histamine receptors to reduce allergic symptoms such as rhinitis, urticaria, angioedema, dermatitis, and hypersensitivity reactions[1][2][5][7]. This combination is typically used for the symptomatic treatment of asthma or severe allergies where both bronchodilation (from Aironyl) and anti-inflammatory/antihistaminic effects (from Apidone) are required. Both products are available as syrups for oral administration. Studies have noted that both formulations are acidic liquids containing sugar; this may increase dental caries risk in children with prolonged use[3][4].

Brand names

Aironyl + Apidone